| Catalog No. | HW315026 |
| Brand | abinScience |
| Host species | Human |
| Species reactivity | Human |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Purity | >95% purity as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target | PLGF, PGF, PlGF, PGFL, Placenta growth factor |
| References | 1. Striglia E, et al. Emerging drugs for the treatment of diabetic retinopathy. Expert Opin Emerg Drugs. 2020 Sep;25(3):261-271. [HW315026] |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | < 10 EU/mg |
| Expression system | Mammalian cells |
| Accession | P49763 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | THR-317, THR317, THR317 |
| Clone ID | THR-317 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Anti-Human PIGF Reference Antibody (THR-317, RUO)
Overview
Images
 SDS-PAGE |
SDS-PAGE for Research Grade Anti-Human PGF/PlGF/PLGF (THR-317) |